Sale!

Acetylcholine Receptor AChR Binding Antibody Test

Original price was: $150.Current price is: $88.

-41%

The Acetylcholine Receptor AChR Binding Antibody Test is a crucial diagnostic tool for detecting autoimmune antibodies associated with Myasthenia Gravis. This specialized blood test measures antibodies that target acetylcholine receptors at neuromuscular junctions, disrupting normal nerve-to-muscle communication. Patients experiencing muscle weakness, drooping eyelids, double vision, or swallowing difficulties should consider this test. Early detection enables proper treatment planning and symptom management. The test uses advanced Enzyme Immunoassay technology for accurate results within one week. Available for only $88 (regularly $150), this essential diagnostic provides valuable insights for neurologists and physicians managing neuromuscular disorders.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Acetylcholine Receptor AChR Binding Antibody Test

Understanding the Acetylcholine Receptor AChR Binding Antibody Test

The Acetylcholine Receptor AChR Binding Antibody Test is a specialized diagnostic examination that plays a critical role in identifying autoimmune neuromuscular disorders. This advanced laboratory analysis detects specific antibodies that target acetylcholine receptors, which are essential proteins located at the neuromuscular junction where nerve cells communicate with muscle fibers.

What Does This Test Measure?

This sophisticated immunoassay specifically measures IgG antibodies that bind to the acetylcholine receptor (AChR) binding sites. These antibodies interfere with normal neuromuscular transmission by:

  • Blocking acetylcholine from binding to its receptors
  • Accelerating receptor degradation
  • Activating complement-mediated destruction of receptors
  • Disrupting normal muscle contraction signals

Clinical Importance and Diagnostic Value

The detection of AChR binding antibodies is highly significant in clinical neurology, as these antibodies are present in approximately 85-90% of patients with generalized Myasthenia Gravis. This autoimmune disorder affects the communication between nerves and muscles, leading to characteristic symptoms of muscle weakness and fatigue.

Who Should Consider This Test?

Patients experiencing the following symptoms should discuss this test with their healthcare provider:

  • Progressive muscle weakness that worsens with activity
  • Drooping eyelids (ptosis)
  • Double vision (diplopia)
  • Difficulty swallowing or chewing
  • Slurred speech
  • Weakness in arms, legs, or neck
  • Shortness of breath during physical exertion
  • Facial muscle weakness

Benefits of Early Detection

Early diagnosis through the AChR Binding Antibody Test provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out Myasthenia Gravis with high specificity
  • Treatment Guidance: Helps neurologists develop targeted treatment plans
  • Disease Monitoring: Enables tracking of disease progression and treatment response
  • Improved Quality of Life: Early intervention can prevent disease complications
  • Family Planning: Provides valuable information for genetic counseling

Understanding Your Test Results

Normal Results

A negative result (typically < 0.02 nmol/L) indicates that AChR binding antibodies are not detected in significant quantities. This result suggests that Myasthenia Gravis is unlikely, though clinical correlation with symptoms is essential.

Abnormal Results

Positive results indicate the presence of AChR binding antibodies and strongly support a diagnosis of autoimmune Myasthenia Gravis. The antibody level often correlates with disease severity, though individual variations exist.

Clinical Interpretation

Your neurologist will interpret results in the context of your clinical presentation, physical examination findings, and other diagnostic tests. Positive results typically confirm autoimmune Myasthenia Gravis, while negative results in symptomatic patients may warrant additional testing for other antibody types.

Test Information and Pricing

Test Details Information
Test Name Acetylcholine Receptor AChR Binding Antibody Test
Discount Price $88 USD
Regular Price $150 USD
Turnaround Time 1 Week
Sample Type 2 mL (1 mL min.) serum from 1 SST
Methodology Enzyme Immunoassay

Pre-Test Instructions

For accurate results, please follow these important preparation guidelines:

  • Avoid general anesthetic or muscle relaxant drugs 24 hours prior to sampling
  • Inform your physician if you have recently received radio-isotopes therapeutically or diagnostically
  • No fasting required for this test
  • Maintain normal medication schedule unless instructed otherwise by your physician

Nationwide Availability

General Genetics Corporation offers the Acetylcholine Receptor AChR Binding Antibody Test at our state-of-the-art facilities across the United States. We have convenient locations in all major metropolitan areas including:

  • New York City and surrounding areas
  • Los Angeles and Southern California
  • Chicago and the Midwest region
  • Houston and Texas locations
  • Phoenix and Arizona facilities
  • Philadelphia and East Coast centers

Take Control of Your Neurological Health

Don’t let unexplained muscle weakness affect your quality of life. The Acetylcholine Receptor AChR Binding Antibody Test provides crucial diagnostic information that can lead to effective treatment and improved symptoms. Our experienced team of neurologists and laboratory specialists are committed to providing accurate, timely results to support your healthcare journey.

Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your neurological health with confidence and clarity.